News Sentiment

IVA sentiment intelligence

Inventiva Sa news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.30 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

75/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+10.0% over one week, +11.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Inventiva (ENXTPA:IVA) Refreshes Its Board, Is The 62% Discount Too Wide?

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 75/100 classification
One-week reaction 10.0% Price confirming higher
Trend fit Trend inactive 11.7% over four weeks
Fair value 12.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 36
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
TradingView 12
Stock Titan 5
TradingKey 4
Idéal Investisseur 2
GlobeNewswire 2
ChartMill 2
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 17
Analyst action 7
Balance sheet 3
Guidance 2
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 52
Simply Wall Street Direct company coverage

Inventiva (ENXTPA:IVA) Refreshes Its Board, Is The 62% Discount Too Wide?

Inventiva (ENXTPA:IVA) has recently revamped its board with three new independent members, drawing investor attention. The company's stock is currently trading at a 62% discount to analyst targets, with a narrative fair value of €10.09 compared to its current price of €3.82, fuel

Tone
Positive 67/100
Event
Analyst action
Published
15 Jul 2026 15:40
Source
Simply Wall Street
Market source Direct company coverage

Inventiva (IVA) Announces Issuance of New EIB Warrants, Completes EIB Warrant Restructuring

Inventiva S.A. (NASDAQ: IVA) has completed the restructuring of its European Investment Bank (EIB) warrants, issuing approximately 15.7 million new warrants and canceling original EIB warrants from January 2024. This move, according to CEO Andrew Obenshain, strengthens the compan

Tone
Positive 75/100
Event
Market update
Published
15 Jul 2026 03:53
Source
Market source
Market source Direct company coverage

Inventiva (ENXTPA:IVA) Puts Its MASH Narrative To The Test After A Recent Rebound

Inventiva (ENXTPA:IVA) stock has experienced mixed performance, with recent gains offset by longer-term declines, as investors focus on its clinical pipeline in MASH and rare diseases. The company's MASH drug, lanifibranor, is in a Phase III trial, with top-line results expected

Tone
Positive 63/100
Event
Earnings
Published
12 Jul 2026 12:40
Source
Market source
Idéal Investisseur Direct company coverage

Inventiva Issues 15.7 Million New Warrants to the EIB and Completes Its Refinancing

Inventiva has completed the final step of its financial restructuring by issuing approximately 15.7 million new warrants to the European Investment Bank (EIB) and cancelling unredeemed old warrants. This action simplifies the capital structure by eliminating anti-dilutive mechani

Tone
Positive 66/100
Event
Balance sheet
Published
10 Jul 2026 10:28
Source
Idéal Investisseur
Stock Titan Direct company coverage

[6-K] Inventiva S.A. Current Report (Foreign Issuer) | IVA SEC Filing - Form 6-K

Inventiva S.A. has completed its warrant restructuring with the European Investment Bank (EIB), issuing 15,677,573 new EIB warrants and cancelling all remaining legacy Tranche B warrants. This move simplifies the company's capital structure by removing specific contractual anti-d

Tone
Positive 71/100
Event
Market update
Published
10 Jul 2026 04:41
Source
Stock Titan
GlobeNewswire Direct company coverage

Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants

Inventiva has completed the final step of its EIB warrant restructuring, issuing approximately 15.7 million new warrants to the European Investment Bank and canceling remaining legacy warrants. This initiative, part of a broader refinancing effort, aims to strengthen Inventiva's

Tone
Positive 66/100
Event
Balance sheet
Published
09 Jul 2026 20:08
Source
GlobeNewswire
Idéal Investisseur Direct company coverage

Inventiva Appoints Three Independent Directors Ahead of Key Lanifibranor Phase

Inventiva has appointed three independent directors, Dr. Barbara Krebs-Pohl, Dr. Anne Prener, and Camilla Soenderby, to its board, effective June 30, 2026. These appointments aim to strengthen expertise in clinical development, commercialization, and financial strategy as the bio

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 10:15
Source
Idéal Investisseur
TradingView Direct company coverage

Inventiva S.A. - American Depository Shares Stock 12‑Month Price Target Raised to $15.69, Implies 257% Upside

Inventiva S.A. (IVA) has seen its average 12-month price target raised from $15.08 to $15.69 by a consensus of 7 analysts, with individual forecasts ranging from $10 to $26 per share. This new target implies a substantial 257% potential upside based on the July 8 closing price. T

Tone
Positive 71/100
Event
Analyst action
Published
09 Jul 2026 04:19
Source
TradingView
Stock Titan Direct company coverage

Inventiva (NASDAQ: IVA) shareholders approve most 2026 meeting resolutions

Inventiva S.A. shareholders approved almost all resolutions at their Combined Shareholders’ General Meeting on June 30, 2026, with a quorum of over 71%. The only resolution rejected was the 31st, which would have authorized share capital increases for a company savings plan, alig

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 10:11
Source
Stock Titan
TradingView Direct company coverage

6IVA Forecast — Price Target — Prediction for 2027

The article provides a forecast and price target for Inventiva SA ADR (6IVA) for 2027 based on analyst ratings. It states that 10 analysts offer 1-year price forecasts, but the specific maximum and minimum estimates are not provided. The content also includes a disclaimer that it

Tone
Neutral 50/100
Event
Analyst action
Published
04 Jul 2026 04:39
Source
TradingView
Via Ritzau Direct company coverage

INVENTIVA

Inventiva, a clinical-stage biopharmaceutical company, announced the results of its Combined Shareholders' General Meeting held on June 30, 2026. Shareholders adopted all resolutions except for the 31st, which was related to share capital increases for a company savings plan and

Tone
Neutral 50/100
Event
Earnings
Published
02 Jul 2026 19:39
Source
Via Ritzau
Moomoo Direct company coverage

Truist Financial Maintains Inventiva(IVA.US) With Buy Rating

Truist Financial has reiterated its Buy rating on Inventiva (IVA.US) stock. The firm's decision to maintain this rating suggests a positive outlook on Inventiva's future performance.

Tone
Positive 70/100
Event
Guidance
Published
02 Jul 2026 15:39
Source
Moomoo
Market source Direct company coverage

Inventiva S.A. (IVA) is One of the Best Stocks Under $10 Offering More Than 50% Upside

Inventiva S.A. (NASDAQ: IVA) has a strong bullish consensus from analysts, with all 9 providing Buy ratings and a median 1-year price target of $15.75, implying over 325% upside. The company recently announced financial updates, including repaying €62 million of EIB loans, buying

Tone
Neutral 50/100
Event
Analyst action
Published
01 Jul 2026 01:40
Source
Market source
TradingView Direct company coverage

Price to earnings forward of Inventiva SA – AQUISEU:IVAP

This article provides financial information for Inventiva SA (IVAP) listed on the Aquis Stock Exchange, specifically focusing on its forward price-to-earnings ratio. The page details that the market is currently closed and no trades have occurred for IVAP. It presents a structure

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 12:40
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Inventiva SA – EURONEXT:IVA

This article provides the "Price to earnings forward" value for Inventiva SA (EURONEXT:IVA). It states that the period value and change are presented, with the data made by humans. The content is primarily a data point display within the TradingView platform.

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 04:40
Source
TradingView
TradingView Direct company coverage

Inventiva SA ADR Actuals & Estimates (LSX:A2P796)

The article provides an overview of Inventiva SA ADR's financial actuals and estimates for its stock (LSX:A2P796) on the Lang & Schwarz Exchange. It highlights the availability of reported financial data and analyst estimates across various financial statements, allowing users to

Tone
Neutral 50/100
Event
Analyst action
Published
27 Jun 2026 01:40
Source
TradingView
TradingView Direct company coverage

Inventiva SA ADR Actuals & Estimates (LS:A2P796)

This page provides financial actuals and estimates for Inventiva SA ADR (LS:A2P796), allowing users to explore reported financial data and analyst estimates. It covers the income statement, balance sheet, and cash flow, enabling comparison of actual results with average, high, an

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 17:39
Source
TradingView
TradingView Direct company coverage

IVA Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Inventiva SA (IVA) stock, based on analyst opinions. It details current stock performance, historical highs and lows, and financial metrics such as market capitalization, earnings, and revenue. The article also includes freque

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 11:40
Source
TradingView
TradingView Direct company coverage

Inventiva SA Actuals & Estimates (EURONEXT:IVA)

This article provides an overview of Inventiva SA's (EURONEXT:IVA) financial actuals and estimates. It covers historical stock performance, analyst forecasts, market capitalization, earnings reports, and other key financial metrics. The article also addresses frequently asked que

Tone
Negative 35/100
Event
Earnings
Published
26 Jun 2026 11:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Inventiva SA – EURONEXT:IVA

This article presents the enterprise value to EBITDA forward data for Inventiva SA (EURONEXT:IVA) as reported on TradingView. It details the financial metric value and its period, along with any changes, but without providing specific figures. The content appears to be a financia

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 07:39
Source
TradingView
TradingView Direct company coverage

Inventiva SA ADR Actuals & Estimates (NASDAQ:IVA)

This article provides access to the financial actuals and estimates for Inventiva S.A. - American Depository Shares (NASDAQ:IVA). Users can explore reported financial data and analyst estimates across income statements, balance sheets, cash flow statements, and valuation metrics,

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 06:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Inventiva SA – EURONEXT:IVA

The article provides financial information for Inventiva SA (IVA) listed on Euronext, specifically detailing its enterprise value to EBIT forward. It is presented within the TradingView platform, indicating market closure and no recent trades. The content primarily focuses on the

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:11
Source
TradingView
GuruFocus Direct company coverage

Inventiva SA Guggenheim Emerging Outlook: Biotech Summit 2026 Transcript

This article provides a transcript from the Inventiva SA Guggenheim Emerging Outlook: Biotech Summit 2026, held on February 11, 2026. During the summit, Inventiva's CEO Andrew Obenshein discussed the company's activities, including an upcoming Phase 3 study readout, which was hig

Tone
Positive 66/100
Event
Guidance
Published
24 Jun 2026 11:09
Source
GuruFocus
TradingKey Direct company coverage

Inventiva SA (IVA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Inventiva SA (IVA), highlighting a "Strong Buy" analyst rating based on 12 analysts, with a target price indicating a 243.00% upside. It includes key financial metrics like market capitalization and current stock price, along with a

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 01:10
Source
TradingKey
TradingKey Direct company coverage

Inventiva SA (IVA) Institutional Confidence

This article from TradingKey provides an overview of Inventiva SA's (IVA) institutional confidence, detailing significant shareholders and their recent activity. Key institutional holders include Samsara BioCapital, Paradigm BioCapital Advisors, and Deep Track Capital, with notab

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:10
Source
TradingKey